Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

BACKGROUND: Population-based studies suggest that emergency department visits and hospitalizations are common among patients receiving chemotherapy and that rates in routine practice are higher than expected from clinical trials. Chemotherapy-related toxicities are often predictable and, consequentl...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Krzyzanowska, Monika K., Julian, Jim A., Powis, Melanie, Howell, Doris, Earle, Craig C., Enright, Katherine A., Mittmann, Nicole, Trudeau, Maureen E., Grunfeld, Eva
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Study Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729066/
https://ncbi.nlm.nih.gov/pubmed/31488084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6099-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items